SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-272462
Filing Date
2021-09-14
Accepted
2021-09-14 10:12:15
Documents
14
Period of Report
2021-09-14
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d232599d8k.htm   iXBRL 8-K 41972
2 EX-3.1 d232599dex31.htm EX-3.1 27521
3 EX-3.2 d232599dex32.htm EX-3.2 54895
  Complete submission text file 0001193125-21-272462.txt   279305

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tbio-20210914.xsd EX-101.SCH 2882
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbio-20210914_lab.xml EX-101.LAB 18873
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbio-20210914_pre.xml EX-101.PRE 11850
7 EXTRACTED XBRL INSTANCE DOCUMENT d232599d8k_htm.xml XML 3554
Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 617-945-7361
Translate Bio, Inc. (Filer) CIK: 0001693415 (see all company filings)

IRS No.: 611807780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38550 | Film No.: 211251586
SIC: 2836 Biological Products, (No Diagnostic Substances)